VXRT (OTC)
VAXART INC
$0.564900
-0.009800 (-1.71%)
Prev close: $0.574700
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Steven Lo
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $136.73M
- Employees
- 115
- P/E (TTM)
- -2.54
- P/B (TTM)
- 4.83
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.04 | $-0.07 | +0.0273 | +40.56% |
|
Jun 2025 (Q2)
|
$-0.07 | $-0.09 | +0.0177 | +20.18% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.10 | +0.0317 | +31.17% |
|
Dec 2024 (Q4)
|
$-0.05 | $-0.10 | +0.0520 | +50.98% |
Financial Statements
| Revenues | $148.20M |
| Benefits Costs and Expenses | $198.60M |
| Costs And Expenses | $198.60M |
| Operating Expenses | $197.05M |
| Depreciation and Amortization | $8.76M |
| Research and Development | $179.08M |
| Other Operating Expenses | $9.21M |
| Operating Income/Loss | -$48.84M |
| Income/Loss From Continuing Operations After Tax | -$50.70M |
| Income/Loss From Continuing Operations Before Tax | -$50.40M |
| Income Tax Expense/Benefit | $308.00K |
| Net Income/Loss | -$50.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$50.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$50.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.22 |
| Basic Average Shares | 236,887,800 |
| Assets | $208.99M |
| Current Assets | $117.37M |
| Cash | $28.80M |
| Other Current Assets | $88.57M |
| Noncurrent Assets | $91.62M |
| Fixed Assets | $6.06M |
| Intangible Assets | $3.01M |
| Other Non-current Assets | $82.55M |
| Liabilities | $182.23M |
| Current Liabilities | $169.30M |
| Accounts Payable | $53.08M |
| Wages | $3.64M |
| Other Current Liabilities | $112.58M |
| Noncurrent Liabilities | $12.93M |
| Equity | $26.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.76M |
| Liabilities And Equity | $208.99M |
| Net Cash Flow From Operating Activities | -$30.29M |
| Net Cash Flow From Operating Activities, Continuing | -$30.29M |
| Net Cash Flow From Investing Activities | $25.05M |
| Net Cash Flow From Investing Activities, Continuing | $25.05M |
| Net Cash Flow From Financing Activities | $93.00K |
| Net Cash Flow From Financing Activities, Continuing | $93.00K |
| Net Cash Flow | -$5.16M |
| Net Cash Flow, Continuing | -$5.16M |
| Comprehensive Income/Loss | -$50.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.73M |
| Other Comprehensive Income/Loss | -$50.73M |